Global Exelon Patch Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Exelon Patch market size was valued at US$ 132 million in 2024 and is forecast to a readjusted size of USD 208 million by 2031 with a CAGR of 6.9% during review period.
Exelon Patch is a transdermal patch that delivers rivastigmine, a medication used to treat mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It works by inhibiting acetylcholinesterase and butyrylcholinesterase, enzymes that break down acetylcholine, a neurotransmitter important for memory and cognition. By maintaining higher acetylcholine levels, Exelon Patch helps improve cognitive function and slow symptom progression. The patch provides a controlled, continuous release of medication over 24 hours, reducing gastrointestinal side effects compared to oral rivastigmine. It is applied once daily to clean, dry skin on the back, upper arm, or chest.
This report is a detailed and comprehensive analysis for global Exelon Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Key Features:
Global Exelon Patch market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (US$/Pc), 2020-2031
Global Exelon Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (US$/Pc), 2020-2031
Global Exelon Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (US$/Pc), 2020-2031
Global Exelon Patch market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (US$/Pc), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Exelon Patch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Exelon Patch market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, LTS Lohmann, Alvogen, Amneal Pharmaceuticals, Sandoz, Mylan, Zydus Life, ONO, Luye Pharmaceutical, Beijing Tide Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Exelon Patch market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Low-dose Patch
Medium-dose Patch
High-dose Patch
Market segment by Application
Hospital
Clinic
Other
Major players covered
Novartis
LTS Lohmann
Alvogen
Amneal Pharmaceuticals
Sandoz
Mylan
Zydus Life
ONO
Luye Pharmaceutical
Beijing Tide Pharmaceutical
Jiangsu Kangbeide Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Exelon Patch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Exelon Patch, with price, sales quantity, revenue, and global market share of Exelon Patch from 2020 to 2025.
Chapter 3, the Exelon Patch competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Exelon Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Exelon Patch market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Exelon Patch.
Chapter 14 and 15, to describe Exelon Patch sales channel, distributors, customers, research findings and conclusion.
Exelon Patch is a transdermal patch that delivers rivastigmine, a medication used to treat mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It works by inhibiting acetylcholinesterase and butyrylcholinesterase, enzymes that break down acetylcholine, a neurotransmitter important for memory and cognition. By maintaining higher acetylcholine levels, Exelon Patch helps improve cognitive function and slow symptom progression. The patch provides a controlled, continuous release of medication over 24 hours, reducing gastrointestinal side effects compared to oral rivastigmine. It is applied once daily to clean, dry skin on the back, upper arm, or chest.
This report is a detailed and comprehensive analysis for global Exelon Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Key Features:
Global Exelon Patch market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (US$/Pc), 2020-2031
Global Exelon Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (US$/Pc), 2020-2031
Global Exelon Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (US$/Pc), 2020-2031
Global Exelon Patch market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (US$/Pc), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Exelon Patch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Exelon Patch market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, LTS Lohmann, Alvogen, Amneal Pharmaceuticals, Sandoz, Mylan, Zydus Life, ONO, Luye Pharmaceutical, Beijing Tide Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Exelon Patch market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Low-dose Patch
Medium-dose Patch
High-dose Patch
Market segment by Application
Hospital
Clinic
Other
Major players covered
Novartis
LTS Lohmann
Alvogen
Amneal Pharmaceuticals
Sandoz
Mylan
Zydus Life
ONO
Luye Pharmaceutical
Beijing Tide Pharmaceutical
Jiangsu Kangbeide Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Exelon Patch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Exelon Patch, with price, sales quantity, revenue, and global market share of Exelon Patch from 2020 to 2025.
Chapter 3, the Exelon Patch competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Exelon Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Exelon Patch market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Exelon Patch.
Chapter 14 and 15, to describe Exelon Patch sales channel, distributors, customers, research findings and conclusion.
Table of Contents
117 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Exelon Patch by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
